Venus Remedies Ltd rallied as much as 13.9 per cent in trade on Wednesday, after the pharma major said it has entered into a collaborative agreement with Israel-based generic drug maker Teva for selling an anti- cancer drug in the Canadian market.
Under this collaboration, Venus Remedies will be initially manufacturing the drug at the Venus Medicine Research Centre, its research unit, for assisting Teva in registrations.
Thereafter, Venus will also use its manufacturing capabilities to support Teva in enhancing the business from this drug in the Canadian market, said a company statement.
Thereafter, Venus will also use its manufacturing capabilities to support Teva in enhancing the business from this drug in the Canadian market, said a company statement.
Nice Post. Thanks for sharing.
ReplyDeleteBurger King IPO
Stock Market March 27
S&P BSE Sensex
Intraday Stocks to Buy or Sell
Thanks for sharing. Really useful information and it’s a great article with good resources. Checkout our Stock Investor website for more latest stock market update.
ReplyDeleteBharat Agri Fert & Realty Stock Price
Bhansali Engg live share price
Bhandari Hosiery Exports Ltd Share Price
Bhakti Gems and Jewellery Share Price